Acrylic acid base adhesive composition, and its medicinal composition and transdermal treating system

An acrylic-based, therapeutic system technology, applied in the field of transdermal therapeutic system and its preparation, can solve the problems of affecting the transdermal release of active drugs, adhesive cohesive force, decrease in shear force, easy crystallization and precipitation, etc. Loading amount and dispersion state, reducing irritation and sensitization, and expanding the effect of variety and dosage

Active Publication Date: 2005-07-20
JIANGSU KANGBEIDE PHARMA
View PDF3 Cites 24 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] 2. The amount of drug loaded is small, otherwise the active drug in the system is unstable and easy to crystallize out, thus affecting the stability of the active drug transdermal release
[0018] 3. It is easy for penetration enhancers and low-molecular plasticizers to migrate to the interface, which reduces the cohesive force and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Acrylic acid base adhesive composition, and its medicinal composition and transdermal treating system
  • Acrylic acid base adhesive composition, and its medicinal composition and transdermal treating system
  • Acrylic acid base adhesive composition, and its medicinal composition and transdermal treating system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0107] The following examples illustrate the present invention, but it must be pointed out that these examples do not constitute any limitation to the scope of the present invention. Unless otherwise stated, parts, percentages and ratios in the examples are by weight.

[0108] 1. Properties of (meth)acrylate copolymers containing (meth)acrylamide or its N, N substituted monomers

[0109] The (meth)acrylate copolymer (A) containing (meth)acrylamide or its N, N substituted monomer prepared by the following polymerization process is called PSA-8-K (for comparative example, without amide function monomer), PSA-9-K, PSA-10-K, PSA-11-K, PSA-12-K, PSA-13-K, PSA-14-K, PSA-15-K, PSA-16- K.

[0110] Polymerization process: Add soft and hard monomers and an appropriate amount of solvent into the reaction tank, add the initiator (benzoyl peroxide), functional monomers, and an appropriate amount of solvent into the dropping funnel, start heating and stirring under nitrogen atmosphere, un...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to an acrylic-based adhesive composition, containing component (A) and component (B). Said component (A) contains (methyl) acrylamide or its N,N-substituted monomer (methyl) acrylate copolymer, and the component (B) contains tertiary amine or quaternary ammonium based (methyl) acrylate copolymer. Said invention also relates to application of said adhesive composition in transdermal therapeutic system, medicine composition containing said adhesive composition and transdermal therapeutic system and its preparation method.

Description

technical field [0001] The present invention relates to an acrylic-based adhesive composition and its application in a transdermal therapeutic system, and relates to a pharmaceutical composition containing the adhesive composition, a transdermal therapeutic system and a preparation method thereof. Background technique [0002] The use of transdermal therapeutic systems, such as active drug-containing pressure sensitive adhesive systems, to control the release of active drugs through the skin is well known. This transdermal therapeutic system mainly includes: polymer matrix (adhesive), active drug, accelerator and other additives. Through techniques such as dissolution (emulsification), mixing, stirring, dispersion, and molding, a transdermal therapeutic system is prepared. The transdermal treatment system is effectively adhered to the skin, so that the active drug diffuses out of the system carrier and enters the recipient's systemic circulation through the skin to produce ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L24/04A61M37/00
Inventor 王树明李益农范小玲王丽薛慧勇柯光明
Owner JIANGSU KANGBEIDE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap